Want to help millions of patients? The MEng program provides students with state-of-the-art technical skills to launch a career in biopharmaceutical processing.
What if there was a way to save people’s lives threatened by debilitating diseases such as Parkinson’s, Alzheimer’s, cancer, and heart disease? Keck Graduate Institute (KGI) in Claremont, CA, educates the next generation of scientists to do just this: to discover the latest drugs that become affordable, safe, and effective medicines and therapies for those that desperately need a cure.
At KGI, our Master of Engineering in Biopharmaceutical Processing (MEng) program teaches students with backgrounds in biology, biochemistry, biotechnology, chemical engineering, or biomedical engineering to discover and manufacture vaccines, proteins, monoclonal antibodies, stem cells biologics, gene therapy, and engineered tissues. Graduates of KGI’s two-year program find rewarding careers in the global and competitive biopharmaceutical industry, where they translate the potential of new drug discoveries to save lives.
Core courses within the MEng program’s curriculum contain workshops and laboratory courses designed to develop technical knowledge and skills in biopharmaceutical process engineering. The curriculum also includes management and regulatory courses so that graduates will have sufficient knowledge in these areas to operate as professionals in the widest variety of corporate settings and be productive members of teams under all circumstances. Our goal is to educate future leaders of the biotech industry.
Here are the top career roles for KGI graduates from the MEng program:
Learn more about the industry.
Download the Program Info Sheet
If there’s anything we can do, be sure to connect with our admissions team. You can also check out more information on cost and aid and how to apply.
Celebrating 25 years of innovation! 25.kgi.edu.